fbpx
November is National Lung Cancer Awareness Month

 

November is officially Lung Cancer Awareness Month.  The event started back in 1995 as Lung Cancer Awareness Day.  As the lung cancer community and the lung cancer movement grew, the awareness activities increased and the day matured into Lung Cancer Awareness Month.  During the month, people throughout the country come together to support the lung […]

 

Learn More

 

 

Study Confirms Stereotactic Ablative Radiotherapy Effectiveness for Early-Stage Lung Cancer

 

St. Louis CyberKnife Proudly Supports the Radiosurgical Research Institute The Radiosurgical Research Institute (RRI), a 501c3 public charity, is the only independent medical research organization committed to improving the outcomes of cancer patients treated with radiosurgery.  Its mission is to advance radiosurgery as a cancer treatment through innovation, education, and quality research in collaboration with […]

 

Learn More

 

 

Study: Physical Activity Benefits Lung Cancer Patients and Survivors

 

A recent study published in the Journal of Thoracic Oncology reviewed the safety, benefits, and application of increasing physical activity and exercise in current and former lung cancer patients. The study sought to summarize the effect on improved outcomes, quality of life, symptom management and other factors. Authors of the study found that the majority of […]

 

Learn More

 

 

Patient Resources: Understanding Oligometastases and SBRT

 

A recent study presented at the 56th Annual Meeting of the American Society for Radiation Oncology (ASTRO) reported that stereotactic body radiation therapy (SBRT) benefits patients with advanced oligometastatic lung cancer. Oligometastasis, a form of metastatic cancer, is the intermediate state of metastasis. Metastatic cancer occurs when cancer cells break away from a primary tumor […]

 

Learn More

 

 

CyberKnife Treatment for Recurrent Lung Cancer

 

In some cases, patients with recurrent lung tumors may have limited options. While a recurrent lung cancer diagnosis may cause feelings of shock and distress, patients can feel hopeful that there are options available to treat cancer that comes back in areas previously treated with surgery or radiation. At St. Louis CyberKnife, our team of […]

 

Learn More

 

 

Cancer Research Month: SBRT Shows Effectiveness for Early-Stage Lung Cancer

 

May is recognized as National Cancer Research Month by The American Association for Cancer Research in an effort to bring national attention to innovative cancer research advancing the fight against the disease. One recent study focused on stereotactic body radiation therapy (SBRT) demonstrated effectiveness for early-stage lung cancer, a common type of cancer that affects […]

 

Learn More

 

 

The Danger of Smokeless Tobacco Products

 

In a recent study completed by the University of Minnesota in Minneapolis, researchers found that higher levels of cancer-causing chemicals in smokeless tobacco products led to greater exposure to certain carcinogens. The cancer-causing chemicals, called tobacco-specific nitrosamines, make up one of the most important groups of tobacco products, particularly cigarettes and tobacco dip. According to […]

 

Learn More

 

 

St. Louis CyberKnife Participates in Lung Cancer 5K

 

St. Louis CyberKnife is a proud sponsor of the Lung Cancer Connection 6th Annual 5K Walk. Each year more than 1,000 people participate to show love and support for lung cancer patients and their families.  The Lung Cancer Connection works to educate residents and the medical community about the risks and warning signs of the […]

 

Learn More

 

 

Presentation: CyberKnife Treatment for Lung Cancer

 

The American Cancer Society predicts more than 3,500 Missouri residents will be diagnosed with lung cancer in 2015. If you or a loved one is facing a lung cancer diagnosis, understanding your treatment options is an important first step.  Lung cancer is one of St. Louis CyberKnife’€™s frequently treated diseases. Learn more about the disease […]

 

Learn More

 

 

Centers for Medicare & Medicaid Services Announce Coverage for Low Dose Computed Tomography Lung Cancer Screenings

 

The Centers for Medicare and Medicaid Services (CMS) recently announced that screenings for lung cancer with low dose computed tomography (LDCT) will now be covered by Medicare. The coverage is effective immediately.  A long-awaited decision, this is the first time Medicare has covered lung cancer screening and is important news for Medicare patients seeking preventive […]

 

Learn More